Volume 7, Issue 2 (2022)
SJMR 2022, 7(2): 103-112 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Mohamadiafrakot M, Mardi S, Abbasi B. World kidney day in COVID-19 years; a narrative review. SJMR 2022; 7 (2) : 5
URL: http://saremjrm.com/article-1-266-en.html
URL: http://saremjrm.com/article-1-266-en.html
1- Department of Internal Medicine, Division of Nephrology, Emam Ali Hospital, Alborz University of Medical Sciences, Karaj, Iran
2- Student Research Committee, Arak University of Medical Sciences, Arak, Iran.
3- Gynecology, Obstetrics, and Infertility Research Center, Sarem Women's Hospital, Iran University of Medical Sciences (IUMS), Tehran, Iran. & National Institute of Genetic Engineering and Biotechnology, Tehran, Iran.
2- Student Research Committee, Arak University of Medical Sciences, Arak, Iran.
3- Gynecology, Obstetrics, and Infertility Research Center, Sarem Women's Hospital, Iran University of Medical Sciences (IUMS), Tehran, Iran. & National Institute of Genetic Engineering and Biotechnology, Tehran, Iran.
Abstract: (1713 Views)
Introduction: The COVID-19 pandemic posed an unprecedented challenge to healthcare systems. COVID's high mortality rates, lack of intensive care unit (ICU) beds, multiple restrictions, and the vaccination process have affected almost all health policies and aspects of individual life. The high mortality rate of severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) infection in patients with chronic diseases, especially CKD, and concerns about the increasing prevalence of non-communicable diseases during the pandemic have drawn much attention to the association between CKD and COVID-19. One of the most critical efforts to combat CKD is the world kidney day (WKD) campaign. World kidney day is the international society of nephrology (ISN) and the international federation of kidney foundations (IFKF) joint initiative to increase public awareness about the importance of kidneys and related diseases, especially CKD. World kidney day 2023, kidney health for all - Preparing for the unexpected, supporting the vulnerable, aims to raise awareness about the importance of kidneys and CKD. Moreover, this campaign encourages screening, and preventive behaviors, in patients at risk for CKD. Based on limited evidence, the COVID-19 pandemic has increased the risk of CKD risk factors such as obesity, diabetes, hypertension, and higher intake of fat and high-salt foods. On the other hand, reducing patients' access to health care has reduced screening in high-risk patients and reduced primary care for CKD patients.
Results:
Learning outcome:
The goal of this paper is to provide an overview of the opportunities, challenges, and solutions to deal with the effects of the COVID-19 pandemic on nephrology healthcare workers. Also:
A1 Explain the 2023 world kidney day (WKD) campaign goals and the effect of the COVID-19 pandemic on each one
A 2. Discuss barriers to quality nephrology patient care in the COVID-19 pandemic and strategies to overcome these barriers.
A 3. Describe how Nephrology health care workers can improve the quality of care to patients with CKD in this era.
Results:
Learning outcome:
The goal of this paper is to provide an overview of the opportunities, challenges, and solutions to deal with the effects of the COVID-19 pandemic on nephrology healthcare workers. Also:
A1 Explain the 2023 world kidney day (WKD) campaign goals and the effect of the COVID-19 pandemic on each one
A 2. Discuss barriers to quality nephrology patient care in the COVID-19 pandemic and strategies to overcome these barriers.
A 3. Describe how Nephrology health care workers can improve the quality of care to patients with CKD in this era.
Article number: 5
Article Type: Analytical Review |
Subject:
Health and safety
Received: 2022/09/6 | Accepted: 2022/09/21 | Published: 2023/03/18
Received: 2022/09/6 | Accepted: 2022/09/21 | Published: 2023/03/18
References
1. Langham RG, Kalantar-Zadeh K, Bonner A, Balducci A, Hsiao LL, Kumaraswami LA, et al. Kidney health for all: bridging the gap in kidney health education and literacy. Nephrol Dial Transplant. 2022 Mar 25;37(4):605-612. doi: 10.1093/ndt/gfac038. [DOI:10.1093/ndt/gfac038]
2. Gansevoort RT, Hilbrands LB. CKD is a key risk factor for COVID-19 mortality. Nat Rev Nephrol. 2020 Dec;16(12):705-706. doi: A10.1038/s41581-020-00349-4. [DOI:10.1038/s41581-020-00349-4]
3. Kazancioğlu R. Risk factors for chronic kidney disease: an update. Kidney Int Suppl (2011). 2013 Dec;3(4):368-371. doi: A 10.1038/kisup.2013.79. [DOI:10.1038/kisup.2013.79]
4. Hsu CC, Hwang SJ, Wen CP, Chang HY, Chen T, Shiu RS, et al. High prevalence and low awareness of CKD in Taiwan: a study on the relationship between serum creatinine and awareness from a nationally representative survey. Am J Kidney Dis. 2006 Nov;48(5):727- A 38. doi: A10.1053/j.ajkd.2006.07.018. [DOI:10.1053/j.ajkd.2006.07.018]
5. Wang F, Zhang L, Wang H; China National Survey of CKD Working Group. Awareness of CKD in China: a national cross-sectional survey. Am J Kidney Dis. 2014 Jun;63(6):1068-70. [DOI:10.1053/j.ajkd.2014.01.012]
6. doi: A 10.1053/j.ajkd.2014.01.012.
7. Chu CD, Chen MH, McCulloch CE, Powe NR, Estrella MM, Shlipak MG, et al. Patient Awareness of CKD: A Systematic Review and Meta-analysis of Patient-Oriented Questions and Study Setting. Kidney Med. 2021 Jun 1;3(4):576- A 585.e1. [DOI:10.1016/j.xkme.2021.03.014]
8. doi: 10.1016/j.xkme.2021.03.014. [DOI:10.1016/j.xkme.2021.03.014]
9. Anwar A, Malik M, Raees V, Anwar A. Role of Mass Media and Public Health Communications in the COVID-19 Pandemic. Cureus. 2020 Sep 14;12(9):e10453. [DOI:10.7759/cureus.10453]
10. doi: 10.7759/cureus.10453. [DOI:10.7759/cureus.10453]
11. Mafra D, Borges NA, de Franca Cardozo LFM, Anjos JS, Black AP, Moraes C, et al. Red meat intake in chronic kidney disease patients: Two sides of the coin. Nutrition. 2018 Feb;46:26- A 32. doi: 10.1016/j.nut.2017.08.015. [DOI:10.1016/j.nut.2017.08.015]
12. Mitchell ES, Yang Q, Behr H, Deluca L, Schaffer P. Self-reported food choices before and during COVID-19 lockdown. MedRxiv. 2020. doi: 10.1101/2020.06.15.20131888 [DOI:10.1101/2020.06.15.20131888]
13. Atlantis E, Goldney RD, Wittert GA. Obesity and depression or anxiety. BMJ. 2009 Oct A 6;339:b3868. doi: 10.1136/bmj.b3868. [DOI:10.1136/bmj.b3868]
14. Komenda P, Ferguson TW, Macdonald K, Rigatto C, Koolage C, Sood MM, et al. Cost-effectiveness of primary screening for CKD: a systematic review. Am J Kidney Dis. 2014 May;63(5):789-97. [DOI:10.1053/j.ajkd.2013.12.012]
15. doi: 10.1053/j.ajkd.2013.12.012. [DOI:10.1053/j.ajkd.2013.12.012]
16. Carter SJ, Baranauskas MN, Fly AD. Considerations for Obesity, Vitamin D, and Physical Activity Amid the COVID-19 Pandemic. Obesity (Silver Spring). 2020 Jul;28(7):1176- A 1177. doi: 10.1002/oby.22838. [DOI:10.1002/oby.22838]
17. Epperla N, McKiernan F. Iatrogenic Cushing syndrome and adrenal insufficiency during concomitant therapy with ritonavir and fluticasone. Springerplus. 2015 Aug 27;4:455. doi: 10.1186/s40064-015-1218-x. [DOI:10.1186/s40064-015-1218-x]
18. Kamrath C, Mönkemöller K, Biester T, Rohrer TR, Warncke K, Hammersen J, et al. Ketoacidosis in Children and Adolescents With Newly Diagnosed Type 1 Diabetes During the COVID-19 Pandemic in Germany. JAMA. 2020 Aug 25;324(8):801-804. [DOI:10.1001/jama.2020.13445]
19. doi: 10.1001/jama.2020.13445. [DOI:10.1001/jama.2020.13445]
20. Akpek M. Does COVID-19 Cause Hypertension? Angiology. 2021 Dec A A 10:33197211053903. [DOI:10.1177/00033197211053903]
21. doi: 10.1177/00033197211053903. [DOI:10.1177/00033197211053903]
22. Hussein NR, M Saleem ZS, Ibrahim N, Musa DH, Naqid IA. The impact of COVID-19 pandemic on the care of patients with kidney diseases in Duhok City, Kurdistan Region of Iraq. Diabetes Metab Syndr. 2020 Nov-Dec;14(6):1551-1553. [DOI:10.1016/j.dsx.2020.08.013]
23. doi: 10.1016/j.dsx.2020.08.013. [DOI:10.1016/j.dsx.2020.08.013]
24. Stevens LA, Fares G, Fleming J, Martin D, Murthy K, Qiu J, et al. Low rates of testing and diagnostic codes usage in a commercial clinical laboratory: evidence for lack of physician awareness of chronic kidney disease. J Am Soc Nephrol. 2005 Aug;16(8):2439-48. [DOI:10.1681/ASN.2005020192]
25. doi: 10.1681/ASN.2005020192. [DOI:10.1681/ASN.2005020192]
26. Alsoufi A, Alsuyihili A, Msherghi A, Elhadi A, Atiyah H, Ashini A, et al. Impact of the COVID-19 pandemic on medical education: Medical students' knowledge, attitudes, and practices regarding electronic learning. PLoS One. A 2020 Nov 25;15(11):e0242905. [DOI:10.1371/journal.pone.0242905]
27. doi: 10.1371/journal.pone.0242905. [DOI:10.1371/journal.pone.0242905]
28. Tan J, Mehrotra A, Nadkarni GN, He JC, Langhoff E, Post J, et al. Telenephrology: Providing Healthcare to Remotely Located Patients with Chronic Kidney Disease. Am J Nephrol. 2018;47(3):200-207. [DOI:10.1159/000488004]
29. doi: 10.1159/000488004. [DOI:10.1159/000488004]
30. Carr EJ, Kronbichler A, Graham-Brown M, Abra G, Argyropoulos C, Harper L, et al. Review of Early Immune Response to SARS-CoV-2 Vaccination Among Patients With CKD. Kidney Int Rep. 2021 Sep;6(9):2292-2304. [DOI:10.1016/j.ekir.2021.06.027]
31. doi: 10.1016/j.ekir.2021.06.027. [DOI:10.1016/j.ekir.2021.06.027]
32. Eren Sadioğlu R, Demir E, Evren E, Aktar M, Şafak S, Artan AS, et al. Antibody response to two doses of inactivated SARS-CoV-2 vaccine (CoronaVac) in kidney transplant recipients. Transpl Infect Dis. 2021 Dec;23(6):e13740. doi: 10.1111/tid.13740. [DOI:10.1111/tid.13740]
33. Simon B, Rubey H, Treipl A, Gromann M, Hemedi B, Zehetmayer S, et al. Haemodialysis patients show a highly diminished antibody response after COVID-19 mRNA vaccination compared with healthy controls. Nephrol Dial Transplant. 2021 Aug A 27;36(9):1709-1716. [DOI:10.1093/ndt/gfab179]
34. doi: 10.1093/ndt/gfab179. [DOI:10.1093/ndt/gfab179]
35. Grupper A, Sharon N, Finn T, Cohen R, Israel M, Agbaria A, et al. Humoral Response to the Pfizer BNT162b2 Vaccine in Patients Undergoing Maintenance Hemodialysis. Clin J Am Soc Nephrol. 2021 Jul;16(7):1037-1042. doi: A 10.2215/CJN.03500321. [DOI:10.2215/CJN.03500321]
36. Holt SG, Mahmoud S, Ahmed W, Acuna JM, Al Madani AK, Eltantawy I, et al. An analysis of antibody responses and clinical sequalae of the Sinopharm HB02 COVID19 vaccine in dialysis patients in the United Arab Emirates. Nephrology (Carlton). 2022 Mar;27(3):260-268. [DOI:10.1111/nep.13980]
37. doi: A 10.1111/nep.13980.
38. Mahalingasivam V, Craik A, Tomlinson LA, Ge L, Hou L, Wang Q, et al. A Systematic Review of COVID-19 and Kidney Transplantation. Kidney Int Rep. 2021 Jan;6(1):24-45. [DOI:10.1016/j.ekir.2020.10.023]
39. doi: 10.1016/j.ekir.2020.10.023. [DOI:10.1016/j.ekir.2020.10.023]
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
